Dear Shareholders, On behalf of the board ("Board") of directors ("Directors") of Austar Lifesciences Limited ("Company"), I am pleased to present the annual report of the Company and its subsidiaries (collectively as the "Group" or "AUSTAR") for the year ended 31 December 2020 ("Year"). The year 2020 has been a challenging year for any individual, company and organization under the impact of the COVID-19 pandemic and its consequential policies. From a global perspective, the pandemic has not been slowing down even though China's pandemic conditions had become fa...